Clinical Applications of Optical Coherence Tomography Angiography. Группа авторов

1Wong WL, Su X, Li X, et al: Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014;2:e106–e116.

2Toto L, Borrelli E, Di Antonio L, Carpineto P, Mastropasqua R: Retinal vascular plexuses’ changes in dry age-related macular degeneration, evaluated by means of optical coherence tomography angiography. Retina 2016;36:1566–1572.

3Mullins RF, Johnson MN, Faidley EA, Skeie JM, Huang J: Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 2011;52:1606–1612.

4Michalska-Malecka KKA, Nowak M, Piewak D: Age related macular degeneration – challenge for future: pathogenesis and new perspectives for the treatment. Eur Geriatr Med 2015;6:69–75.

5Bhutto I, Lutty G: Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Aspects Med 2012;33:295–317.

      6McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA: Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:4982–4991.

      7Biesemeier A, Taubitz T, Julien S, Yoeruek E, Schraermeyer U: Choriocapillaris breakdown precedes retinal degeneration in age-related macular degeneration. Neurobiol Aging 2014;35:2562–2573.

8Lane M, Moult EM, Novais EA, et al: Visualizing the choriocapillaris under drusen: comparing 1050-nm swept-source versus 840-nm spectral-domain optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2016;57:OCT585–590.

9Waheed NK, Moult EM, Fujimoto JG, Rosenfeld PJ: Optical coherence tomography angiography of dry age-related macular degeneration. Dev Ophthalmol 2016;56:91–100.

10Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP: Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol 1999;83:358–368.

11Cicinelli MV, Rabiolo A, Sacconi R, et al: Optical coherence tomography angiography in dry age-related macular degeneration. Surv Ophthalmol 2018;63:236–244.

12Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L: The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98:1128–1134.

13Ferris FL 3rd, Wilkinson CP, Bird A, et al: Clinical classification of age-related macular degeneration. Ophthalmology 2013;120:844–851.

14Coleman HR, Chan CC, Ferris FL 3rd, Chew EY: Age-related macular degeneration. Lancet 2008;372:1835–1845.

15Lee EK, Yu HG: Ganglion cell-inner plexiform layer and peripapillary retinal nerve fiber layer thicknesses in age-related macular degeneration. Invest Ophthalmol Vis Sci 2015;56:3976–3983.

16Moult EM, Waheed NK, Novais EA, et al: Swept-source optical coherence tomography angiography reveals choriocapillaris alterations in eyes with nascent geographic atrophy and drusen-associated geographic atrophy. Retina 2016;36(suppl 1):S2–S11.

17Yonekawa Y, Miller JW, Kim IK: Age-related macular degeneration: advances in management and diagnosis. J Clin Med 2015;4:343–359.

18Ferris FL 3rd, Fine SL, Hyman L: Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640–1642.

19Velez-Montoya R, Oliver SC, Olson JL, Fine SL, Mandava N, Quiroz-Mercado H: Current knowledge and trends in age-related macular degeneration: today’s and future treatments. Retina 2013;33:1487–1502.

20Mokwa NF, Ristau T, Keane PA, Kirchhof B, Sadda SR, Liakopoulos S: Grading of age-related macular degeneration: comparison between color fundus photography, fluorescein angiography, and spectral domain optical coherence tomography. J Ophthalmol 2013;2013:385915.

21Bird AC, Bressler NM, Bressler SB, et al: An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367–374.

22Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE: Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 2001;42:1051–1056.

23Sadda SR, Guymer R, Holz FG, et al: Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology 2018;125:537–548.

24de Carlo TE, Romano A, Waheed N, Duker JS: A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous 2015;1:5.

25Abdelfattah NS, Zhang H, Boyer DS, et al: Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye. Invest Ophthalmol Vis Sci 2016;57:1839–1846.

26Ouyang Y, Heussen FM, Hariri A, Keane PA, Sadda SR: Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration. Ophthalmology 2013;120:2656–2665.

27Schlanitz FG, Sacu S, Baumann B, et al: Identification of drusen characteristics in age-related macular degeneration by polarization-sensitive optical coherence tomography. Am J Ophthalmol 2015;160:335–344.e1.

28Querques G, Querques L, Forte R, Massamba N, Coscas F, Souied EH: Choroidal changes associated with reticular pseudodrusen. Invest Ophthalmol Vis Sci 2012;53:1258–1263.

      29Thorell MR, Goldhardt R, Nunes RP, et al: Association between subfoveal choroidal thickness, reticular pseudodrusen, and geographic atrophy in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina 2015;46:513–521.

30Schmitz-Valckenberg S, Alten F, Steinberg JS, et al: Reticular drusen associated